FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:CLYBL-UBAC2 (FusionGDB2 ID:17481)

Fusion Gene Summary for CLYBL-UBAC2

check button Fusion gene summary
Fusion gene informationFusion gene name: CLYBL-UBAC2
Fusion gene ID: 17481
HgeneTgene
Gene symbol

CLYBL

UBAC2

Gene ID

171425

337867

Gene namecitramalyl-CoA lyaseUBA domain containing 2
SynonymsCLBPHGDHL1
Cytomap

13q32.3

13q32.3

Type of geneprotein-codingprotein-coding
Descriptioncitramalyl-CoA lyase, mitochondrial(3S)-malyl-CoA thioesterasebeta-methylmalate synthasecitrate lyase beta likecitrate lyase subunit beta-like protein, mitochondrialmalate synthaseubiquitin-associated domain-containing protein 2RP11-178C10.1UBA domain-containing protein 2phosphoglycerate dehydrogenase like 1phosphoglycerate dehydrogenase-like protein 1
Modification date2020031320200320
UniProtAcc

Q8N0X4

.
Ensembl transtripts involved in fusion geneENST00000339105, ENST00000376354, 
ENST00000376355, ENST00000376360, 
ENST00000444838, 
ENST00000460562, 
ENST00000376440, ENST00000403766, 
Fusion gene scores* DoF score7 X 8 X 4=2249 X 10 X 6=540
# samples 811
** MAII scorelog2(8/224*10)=-1.48542682717024
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(11/540*10)=-2.29545588352617
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: CLYBL [Title/Abstract] AND UBAC2 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointUBAC2(99890808)-CLYBL(100543572), # samples:2
UBAC2(99970323)-CLYBL(100425078), # samples:2
CLYBL(100425264)-UBAC2(100020041), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneCLYBL

GO:0070207

protein homotrimerization

29056341

HgeneCLYBL

GO:0106064

regulation of cobalamin metabolic process

29056341

TgeneUBAC2

GO:0070972

protein localization to endoplasmic reticulum

23297223


check buttonFusion gene breakpoints across CLYBL (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across UBAC2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4LUSCTCGA-77-A5GH-01ACLYBLchr13

100425264

-UBAC2chr13

100020041

+


Top

Fusion Gene ORF analysis for CLYBL-UBAC2

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
5CDS-3UTRENST00000339105ENST00000460562CLYBLchr13

100425264

-UBAC2chr13

100020041

+
5CDS-3UTRENST00000376354ENST00000460562CLYBLchr13

100425264

-UBAC2chr13

100020041

+
5CDS-3UTRENST00000376355ENST00000460562CLYBLchr13

100425264

-UBAC2chr13

100020041

+
5CDS-3UTRENST00000376360ENST00000460562CLYBLchr13

100425264

-UBAC2chr13

100020041

+
5CDS-3UTRENST00000444838ENST00000460562CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000339105ENST00000376440CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000339105ENST00000403766CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000376354ENST00000376440CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000376354ENST00000403766CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000376355ENST00000376440CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000376355ENST00000403766CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000376360ENST00000376440CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000376360ENST00000403766CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000444838ENST00000376440CLYBLchr13

100425264

-UBAC2chr13

100020041

+
In-frameENST00000444838ENST00000403766CLYBLchr13

100425264

-UBAC2chr13

100020041

+

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000376355CLYBLchr13100425264-ENST00000403766UBAC2chr13100020041+71328031507158
ENST00000376355CLYBLchr13100425264-ENST00000376440UBAC2chr13100020041+160028031507158
ENST00000444838CLYBLchr13100425264-ENST00000403766UBAC2chr13100020041+70927627503158
ENST00000444838CLYBLchr13100425264-ENST00000376440UBAC2chr13100020041+159627627503158
ENST00000376360CLYBLchr13100425264-ENST00000403766UBAC2chr13100020041+70927627503158
ENST00000376360CLYBLchr13100425264-ENST00000376440UBAC2chr13100020041+159627627503158
ENST00000376354CLYBLchr13100425264-ENST00000403766UBAC2chr13100020041+6882556482158
ENST00000376354CLYBLchr13100425264-ENST00000376440UBAC2chr13100020041+15752556482158
ENST00000339105CLYBLchr13100425264-ENST00000403766UBAC2chr13100020041+6822490476158
ENST00000339105CLYBLchr13100425264-ENST00000376440UBAC2chr13100020041+15692490476158

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000376355ENST00000403766CLYBLchr13100425264-UBAC2chr13100020041+0.0030512620.9969488
ENST00000376355ENST00000376440CLYBLchr13100425264-UBAC2chr13100020041+0.0020652530.9979348
ENST00000444838ENST00000403766CLYBLchr13100425264-UBAC2chr13100020041+0.0034863870.99651366
ENST00000444838ENST00000376440CLYBLchr13100425264-UBAC2chr13100020041+0.0021916370.9978084
ENST00000376360ENST00000403766CLYBLchr13100425264-UBAC2chr13100020041+0.0034863870.99651366
ENST00000376360ENST00000376440CLYBLchr13100425264-UBAC2chr13100020041+0.0021916370.9978084
ENST00000376354ENST00000403766CLYBLchr13100425264-UBAC2chr13100020041+0.0032218430.9967782
ENST00000376354ENST00000376440CLYBLchr13100425264-UBAC2chr13100020041+0.0026042010.99739575
ENST00000339105ENST00000403766CLYBLchr13100425264-UBAC2chr13100020041+0.0031691680.9968309
ENST00000339105ENST00000376440CLYBLchr13100425264-UBAC2chr13100020041+0.0024611590.9975388

Top

Fusion Genomic Features for CLYBL-UBAC2


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.
genomic feature

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for CLYBL-UBAC2


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr13:99890808/chr13:100543572)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
CLYBL

Q8N0X4

.
FUNCTION: Mitochondrial citramalyl-CoA lyase indirectly involved in the vitamin B12 metabolism (PubMed:29056341). Converts citramalyl-CoA into acetyl-CoA and pyruvate in the C5-dicarboxylate catabolism pathway (PubMed:29056341). The C5-dicarboxylate catabolism pathway is required to detoxify itaconate, a vitamin B12-poisoning metabolite (PubMed:29056341). Also acts as a malate synthase in vitro, converting glyoxylate and acetyl-CoA to malate (PubMed:29056341, PubMed:24334609). Also displays malyl-CoA thioesterase activity (PubMed:29056341). Also acts as a beta-methylmalate synthase in vitro, by mediating conversion of glyoxylate and propionyl-CoA to beta-methylmalate (PubMed:24334609, PubMed:29056341). Also has very weak citramalate synthase activity in vitro (PubMed:24334609, PubMed:29056341). {ECO:0000269|PubMed:24334609, ECO:0000269|PubMed:29056341}.FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneUBAC2chr13:100425264chr13:100020041ENST0000037644047304_344234310.0DomainUBA
TgeneUBAC2chr13:100425264chr13:100020041ENST0000040376669304_344269345.0DomainUBA

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneCLYBLchr13:100425264chr13:100020041ENST00000339105-29272_27383361.0RegionSubstrate binding
HgeneCLYBLchr13:100425264chr13:100020041ENST00000376354-27272_27383307.0RegionSubstrate binding
HgeneCLYBLchr13:100425264chr13:100020041ENST00000376355-28272_273831839.6666666666667RegionSubstrate binding
HgeneCLYBLchr13:100425264chr13:100020041ENST00000376360-28272_27383341.0RegionSubstrate binding
TgeneUBAC2chr13:100425264chr13:100020041ENST0000037644047113_125234310.0Topological domainCytoplasmic
TgeneUBAC2chr13:100425264chr13:100020041ENST0000037644047147_163234310.0Topological domainExtracellular
TgeneUBAC2chr13:100425264chr13:100020041ENST0000037644047185_344234310.0Topological domainCytoplasmic
TgeneUBAC2chr13:100425264chr13:100020041ENST000003764404736_91234310.0Topological domainExtracellular
TgeneUBAC2chr13:100425264chr13:100020041ENST0000040376669113_125269345.0Topological domainCytoplasmic
TgeneUBAC2chr13:100425264chr13:100020041ENST0000040376669147_163269345.0Topological domainExtracellular
TgeneUBAC2chr13:100425264chr13:100020041ENST0000040376669185_344269345.0Topological domainCytoplasmic
TgeneUBAC2chr13:100425264chr13:100020041ENST000004037666936_91269345.0Topological domainExtracellular
TgeneUBAC2chr13:100425264chr13:100020041ENST0000037644047126_146234310.0TransmembraneHelical
TgeneUBAC2chr13:100425264chr13:100020041ENST0000037644047164_184234310.0TransmembraneHelical
TgeneUBAC2chr13:100425264chr13:100020041ENST000003764404792_112234310.0TransmembraneHelical
TgeneUBAC2chr13:100425264chr13:100020041ENST0000040376669126_146269345.0TransmembraneHelical
TgeneUBAC2chr13:100425264chr13:100020041ENST0000040376669164_184269345.0TransmembraneHelical
TgeneUBAC2chr13:100425264chr13:100020041ENST000004037666992_112269345.0TransmembraneHelical


Top

Fusion Gene Sequence for CLYBL-UBAC2


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.
>17481_17481_1_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000339105_UBAC2_chr13_100020041_ENST00000376440_length(transcript)=1569nt_BP=249nt
ATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAGGCTGAAAGCGTCTCTAGCAGCTGATATCCCC
AGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTATGTACCTGGAAATGATGAAAAGAAAATAAAG
AAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGCAAACAAAAAGGGAGGAATGATCAATTGGAAT
CGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTCTGAGCCAGCAGCGCCCCCTCTAGAAGTTTCT
GAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGCCCTGAGAGCTTCAAACAATGACCTCAATGTC
GCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGCAGCCGAGTGACAGTGCGTGGTCCCCACCATC
AGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTTCCACCGCACCCCTGCCCTCAACCGCAAGACT
GTTGCCGTTTTAGTGTGGAGATAAGTTTGCCATTACATTAGCATGTATTTTCTATCTATATTTTTTATTGGGCATTTTCCCTAGGTTGGA
GAGTCAGCACTCGTTTTGAATGTGTTTAAAATGCATTAAAATGGAAGATTTCTGCAGGCAGTTGAATGGCACTCCAGATGGGGAATTGCT
GTAACCCTCTTACTGTAACATGTCATCTCCTGCGTCGTGATGGGGAGAGGGTAATGTTACTTCACAAAGGACATGTCAGATCCTTCTTCA
TGGACTTTTTTAGTTACTGTTTTTTCTCTCAAACTTGTTTTCGAATCTCCTGGGAGTGAGGGAGAAACAGGGAGCTGAATCCTCCCCCAA
GCTGTTCCAGGCCAGAGGACTCTGCAGTACCTTCTCCTACATCTAGTAACAAAGAATGGTGATAACCATGCACTGGTTCAAGGTTCTGGA
GTTCTCCATGAAACTTGGGTTAATTTTGCTCAGAGTATCCAGAGTTAGCCACTAGGCTGCGGGTGAAATGGGATGGAGAAGAACAACAGC
AGGCTTCCTGGAGCCACATGGGCTGACTAGGGCACTCTGTGGCTGGCCTGGCATGGGCTCAGCCCAGGAAGAGGAGAAACGATCCCTTGC
CTGCCCCTCCCTGTGGCAGGGCTAACTGCCTGGCCCTCCTGGCTCGCAGCCAGCCAGCCCCCTGGCAGCAGGTTCTCCTCAGGGCTTGGG
TCTTCAACCTGTGGCGACAGGAGGCAGGGCAGACTGTGGAGGACAGGATGCAGGTCAGGGAGAGGGAAGGCAGGGGTGGACCGCCATGAG
CATGAAAAGACCCGAAGCAAGTTGACTCTTGCAATGTGCAACTGTTATGTTCTGCAAAATGAGCAACGATGTATCAAATTGATGCAAATT

>17481_17481_1_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000339105_UBAC2_chr13_100020041_ENST00000376440_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------
>17481_17481_2_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000339105_UBAC2_chr13_100020041_ENST00000403766_length(transcript)=682nt_BP=249nt
ATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAGGCTGAAAGCGTCTCTAGCAGCTGATATCCCC
AGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTATGTACCTGGAAATGATGAAAAGAAAATAAAG
AAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGCAAACAAAAAGGGAGGAATGATCAATTGGAAT
CGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTCTGAGCCAGCAGCGCCCCCTCTAGAAGTTTCT
GAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGCCCTGAGAGCTTCAAACAATGACCTCAATGTC
GCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGCAGCCGAGTGACAGTGCGTGGTCCCCACCATC
AGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTTCCACCGCACCCCTGCCCTCAACCGCAAGACT

>17481_17481_2_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000339105_UBAC2_chr13_100020041_ENST00000403766_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------
>17481_17481_3_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376354_UBAC2_chr13_100020041_ENST00000376440_length(transcript)=1575nt_BP=255nt
GGGAAGATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAGGCTGAAAGCGTCTCTAGCAGCTGAT
ATCCCCAGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTATGTACCTGGAAATGATGAAAAGAAA
ATAAAGAAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGCAAACAAAAAGGGAGGAATGATCAAT
TGGAATCGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTCTGAGCCAGCAGCGCCCCCTCTAGAA
GTTTCTGAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGCCCTGAGAGCTTCAAACAATGACCTC
AATGTCGCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGCAGCCGAGTGACAGTGCGTGGTCCCC
ACCATCAGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTTCCACCGCACCCCTGCCCTCAACCGC
AAGACTGTTGCCGTTTTAGTGTGGAGATAAGTTTGCCATTACATTAGCATGTATTTTCTATCTATATTTTTTATTGGGCATTTTCCCTAG
GTTGGAGAGTCAGCACTCGTTTTGAATGTGTTTAAAATGCATTAAAATGGAAGATTTCTGCAGGCAGTTGAATGGCACTCCAGATGGGGA
ATTGCTGTAACCCTCTTACTGTAACATGTCATCTCCTGCGTCGTGATGGGGAGAGGGTAATGTTACTTCACAAAGGACATGTCAGATCCT
TCTTCATGGACTTTTTTAGTTACTGTTTTTTCTCTCAAACTTGTTTTCGAATCTCCTGGGAGTGAGGGAGAAACAGGGAGCTGAATCCTC
CCCCAAGCTGTTCCAGGCCAGAGGACTCTGCAGTACCTTCTCCTACATCTAGTAACAAAGAATGGTGATAACCATGCACTGGTTCAAGGT
TCTGGAGTTCTCCATGAAACTTGGGTTAATTTTGCTCAGAGTATCCAGAGTTAGCCACTAGGCTGCGGGTGAAATGGGATGGAGAAGAAC
AACAGCAGGCTTCCTGGAGCCACATGGGCTGACTAGGGCACTCTGTGGCTGGCCTGGCATGGGCTCAGCCCAGGAAGAGGAGAAACGATC
CCTTGCCTGCCCCTCCCTGTGGCAGGGCTAACTGCCTGGCCCTCCTGGCTCGCAGCCAGCCAGCCCCCTGGCAGCAGGTTCTCCTCAGGG
CTTGGGTCTTCAACCTGTGGCGACAGGAGGCAGGGCAGACTGTGGAGGACAGGATGCAGGTCAGGGAGAGGGAAGGCAGGGGTGGACCGC
CATGAGCATGAAAAGACCCGAAGCAAGTTGACTCTTGCAATGTGCAACTGTTATGTTCTGCAAAATGAGCAACGATGTATCAAATTGATG

>17481_17481_3_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376354_UBAC2_chr13_100020041_ENST00000376440_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------
>17481_17481_4_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376354_UBAC2_chr13_100020041_ENST00000403766_length(transcript)=688nt_BP=255nt
GGGAAGATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAGGCTGAAAGCGTCTCTAGCAGCTGAT
ATCCCCAGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTATGTACCTGGAAATGATGAAAAGAAA
ATAAAGAAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGCAAACAAAAAGGGAGGAATGATCAAT
TGGAATCGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTCTGAGCCAGCAGCGCCCCCTCTAGAA
GTTTCTGAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGCCCTGAGAGCTTCAAACAATGACCTC
AATGTCGCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGCAGCCGAGTGACAGTGCGTGGTCCCC
ACCATCAGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTTCCACCGCACCCCTGCCCTCAACCGC

>17481_17481_4_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376354_UBAC2_chr13_100020041_ENST00000403766_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------
>17481_17481_5_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376355_UBAC2_chr13_100020041_ENST00000376440_length(transcript)=1600nt_BP=280nt
AGGCAAAGGGCGGGGCGCGCGCGTCGGGAAGATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAG
GCTGAAAGCGTCTCTAGCAGCTGATATCCCCAGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTA
TGTACCTGGAAATGATGAAAAGAAAATAAAGAAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGC
AAACAAAAAGGGAGGAATGATCAATTGGAATCGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTC
TGAGCCAGCAGCGCCCCCTCTAGAAGTTTCTGAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGC
CCTGAGAGCTTCAAACAATGACCTCAATGTCGCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGC
AGCCGAGTGACAGTGCGTGGTCCCCACCATCAGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTT
CCACCGCACCCCTGCCCTCAACCGCAAGACTGTTGCCGTTTTAGTGTGGAGATAAGTTTGCCATTACATTAGCATGTATTTTCTATCTAT
ATTTTTTATTGGGCATTTTCCCTAGGTTGGAGAGTCAGCACTCGTTTTGAATGTGTTTAAAATGCATTAAAATGGAAGATTTCTGCAGGC
AGTTGAATGGCACTCCAGATGGGGAATTGCTGTAACCCTCTTACTGTAACATGTCATCTCCTGCGTCGTGATGGGGAGAGGGTAATGTTA
CTTCACAAAGGACATGTCAGATCCTTCTTCATGGACTTTTTTAGTTACTGTTTTTTCTCTCAAACTTGTTTTCGAATCTCCTGGGAGTGA
GGGAGAAACAGGGAGCTGAATCCTCCCCCAAGCTGTTCCAGGCCAGAGGACTCTGCAGTACCTTCTCCTACATCTAGTAACAAAGAATGG
TGATAACCATGCACTGGTTCAAGGTTCTGGAGTTCTCCATGAAACTTGGGTTAATTTTGCTCAGAGTATCCAGAGTTAGCCACTAGGCTG
CGGGTGAAATGGGATGGAGAAGAACAACAGCAGGCTTCCTGGAGCCACATGGGCTGACTAGGGCACTCTGTGGCTGGCCTGGCATGGGCT
CAGCCCAGGAAGAGGAGAAACGATCCCTTGCCTGCCCCTCCCTGTGGCAGGGCTAACTGCCTGGCCCTCCTGGCTCGCAGCCAGCCAGCC
CCCTGGCAGCAGGTTCTCCTCAGGGCTTGGGTCTTCAACCTGTGGCGACAGGAGGCAGGGCAGACTGTGGAGGACAGGATGCAGGTCAGG
GAGAGGGAAGGCAGGGGTGGACCGCCATGAGCATGAAAAGACCCGAAGCAAGTTGACTCTTGCAATGTGCAACTGTTATGTTCTGCAAAA

>17481_17481_5_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376355_UBAC2_chr13_100020041_ENST00000376440_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------
>17481_17481_6_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376355_UBAC2_chr13_100020041_ENST00000403766_length(transcript)=713nt_BP=280nt
AGGCAAAGGGCGGGGCGCGCGCGTCGGGAAGATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAG
GCTGAAAGCGTCTCTAGCAGCTGATATCCCCAGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTA
TGTACCTGGAAATGATGAAAAGAAAATAAAGAAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGC
AAACAAAAAGGGAGGAATGATCAATTGGAATCGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTC
TGAGCCAGCAGCGCCCCCTCTAGAAGTTTCTGAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGC
CCTGAGAGCTTCAAACAATGACCTCAATGTCGCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGC
AGCCGAGTGACAGTGCGTGGTCCCCACCATCAGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTT

>17481_17481_6_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376355_UBAC2_chr13_100020041_ENST00000403766_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------
>17481_17481_7_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376360_UBAC2_chr13_100020041_ENST00000376440_length(transcript)=1596nt_BP=276nt
AAAGGGCGGGGCGCGCGCGTCGGGAAGATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAGGCTG
AAAGCGTCTCTAGCAGCTGATATCCCCAGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTATGTA
CCTGGAAATGATGAAAAGAAAATAAAGAAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGCAAAC
AAAAAGGGAGGAATGATCAATTGGAATCGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTCTGAG
CCAGCAGCGCCCCCTCTAGAAGTTTCTGAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGCCCTG
AGAGCTTCAAACAATGACCTCAATGTCGCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGCAGCC
GAGTGACAGTGCGTGGTCCCCACCATCAGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTTCCAC
CGCACCCCTGCCCTCAACCGCAAGACTGTTGCCGTTTTAGTGTGGAGATAAGTTTGCCATTACATTAGCATGTATTTTCTATCTATATTT
TTTATTGGGCATTTTCCCTAGGTTGGAGAGTCAGCACTCGTTTTGAATGTGTTTAAAATGCATTAAAATGGAAGATTTCTGCAGGCAGTT
GAATGGCACTCCAGATGGGGAATTGCTGTAACCCTCTTACTGTAACATGTCATCTCCTGCGTCGTGATGGGGAGAGGGTAATGTTACTTC
ACAAAGGACATGTCAGATCCTTCTTCATGGACTTTTTTAGTTACTGTTTTTTCTCTCAAACTTGTTTTCGAATCTCCTGGGAGTGAGGGA
GAAACAGGGAGCTGAATCCTCCCCCAAGCTGTTCCAGGCCAGAGGACTCTGCAGTACCTTCTCCTACATCTAGTAACAAAGAATGGTGAT
AACCATGCACTGGTTCAAGGTTCTGGAGTTCTCCATGAAACTTGGGTTAATTTTGCTCAGAGTATCCAGAGTTAGCCACTAGGCTGCGGG
TGAAATGGGATGGAGAAGAACAACAGCAGGCTTCCTGGAGCCACATGGGCTGACTAGGGCACTCTGTGGCTGGCCTGGCATGGGCTCAGC
CCAGGAAGAGGAGAAACGATCCCTTGCCTGCCCCTCCCTGTGGCAGGGCTAACTGCCTGGCCCTCCTGGCTCGCAGCCAGCCAGCCCCCT
GGCAGCAGGTTCTCCTCAGGGCTTGGGTCTTCAACCTGTGGCGACAGGAGGCAGGGCAGACTGTGGAGGACAGGATGCAGGTCAGGGAGA
GGGAAGGCAGGGGTGGACCGCCATGAGCATGAAAAGACCCGAAGCAAGTTGACTCTTGCAATGTGCAACTGTTATGTTCTGCAAAATGAG

>17481_17481_7_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376360_UBAC2_chr13_100020041_ENST00000376440_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------
>17481_17481_8_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376360_UBAC2_chr13_100020041_ENST00000403766_length(transcript)=709nt_BP=276nt
AAAGGGCGGGGCGCGCGCGTCGGGAAGATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAGGCTG
AAAGCGTCTCTAGCAGCTGATATCCCCAGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTATGTA
CCTGGAAATGATGAAAAGAAAATAAAGAAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGCAAAC
AAAAAGGGAGGAATGATCAATTGGAATCGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTCTGAG
CCAGCAGCGCCCCCTCTAGAAGTTTCTGAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGCCCTG
AGAGCTTCAAACAATGACCTCAATGTCGCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGCAGCC
GAGTGACAGTGCGTGGTCCCCACCATCAGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTTCCAC

>17481_17481_8_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000376360_UBAC2_chr13_100020041_ENST00000403766_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------
>17481_17481_9_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000444838_UBAC2_chr13_100020041_ENST00000376440_length(transcript)=1596nt_BP=276nt
AAAGGGCGGGGCGCGCGCGTCGGGAAGATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAGGCTG
AAAGCGTCTCTAGCAGCTGATATCCCCAGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTATGTA
CCTGGAAATGATGAAAAGAAAATAAAGAAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGCAAAC
AAAAAGGGAGGAATGATCAATTGGAATCGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTCTGAG
CCAGCAGCGCCCCCTCTAGAAGTTTCTGAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGCCCTG
AGAGCTTCAAACAATGACCTCAATGTCGCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGCAGCC
GAGTGACAGTGCGTGGTCCCCACCATCAGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTTCCAC
CGCACCCCTGCCCTCAACCGCAAGACTGTTGCCGTTTTAGTGTGGAGATAAGTTTGCCATTACATTAGCATGTATTTTCTATCTATATTT
TTTATTGGGCATTTTCCCTAGGTTGGAGAGTCAGCACTCGTTTTGAATGTGTTTAAAATGCATTAAAATGGAAGATTTCTGCAGGCAGTT
GAATGGCACTCCAGATGGGGAATTGCTGTAACCCTCTTACTGTAACATGTCATCTCCTGCGTCGTGATGGGGAGAGGGTAATGTTACTTC
ACAAAGGACATGTCAGATCCTTCTTCATGGACTTTTTTAGTTACTGTTTTTTCTCTCAAACTTGTTTTCGAATCTCCTGGGAGTGAGGGA
GAAACAGGGAGCTGAATCCTCCCCCAAGCTGTTCCAGGCCAGAGGACTCTGCAGTACCTTCTCCTACATCTAGTAACAAAGAATGGTGAT
AACCATGCACTGGTTCAAGGTTCTGGAGTTCTCCATGAAACTTGGGTTAATTTTGCTCAGAGTATCCAGAGTTAGCCACTAGGCTGCGGG
TGAAATGGGATGGAGAAGAACAACAGCAGGCTTCCTGGAGCCACATGGGCTGACTAGGGCACTCTGTGGCTGGCCTGGCATGGGCTCAGC
CCAGGAAGAGGAGAAACGATCCCTTGCCTGCCCCTCCCTGTGGCAGGGCTAACTGCCTGGCCCTCCTGGCTCGCAGCCAGCCAGCCCCCT
GGCAGCAGGTTCTCCTCAGGGCTTGGGTCTTCAACCTGTGGCGACAGGAGGCAGGGCAGACTGTGGAGGACAGGATGCAGGTCAGGGAGA
GGGAAGGCAGGGGTGGACCGCCATGAGCATGAAAAGACCCGAAGCAAGTTGACTCTTGCAATGTGCAACTGTTATGTTCTGCAAAATGAG

>17481_17481_9_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000444838_UBAC2_chr13_100020041_ENST00000376440_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------
>17481_17481_10_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000444838_UBAC2_chr13_100020041_ENST00000403766_length(transcript)=709nt_BP=276nt
AAAGGGCGGGGCGCGCGCGTCGGGAAGATGGCGCTACGTCTGCTGCGGAGGGCGGCGCGCGGAGCTGCGGCGGCGGCGCTGCTGAGGCTG
AAAGCGTCTCTAGCAGCTGATATCCCCAGACTTGGATATAGTTCCTCATCCCATCACAAGTACATCCCCCGGAGGGCAGTGCTTTATGTA
CCTGGAAATGATGAAAAGAAAATAAAGAAGATTCCATCCCTGAATGTAGATTGTGCAGTGCTCGACTGTGAGGATGGAGTGGCTGCAAAC
AAAAAGGGAGGAATGATCAATTGGAATCGTCTTTTTCCTCCTTTACGTCAGCGACAAAACGTAAACTATCAGGGCGGTCGGCAGTCTGAG
CCAGCAGCGCCCCCTCTAGAAGTTTCTGAGGAACAGGTCGCCCGGCTCATGGAGATGGGATTTTCCAGAGGTGATGCTTTGGAAGCCCTG
AGAGCTTCAAACAATGACCTCAATGTCGCCACCAACTTCCTGCTGCAGCACTGATAGTCCCAGGCCAACACTGGGACCGGACCGGCAGCC
GAGTGACAGTGCGTGGTCCCCACCATCAGATCAGCCCGGGGACCGAGCATCTCTGGTGCTGATGTTCTTGTGGGAAGAGGGAGGTTCCAC

>17481_17481_10_CLYBL-UBAC2_CLYBL_chr13_100425264_ENST00000444838_UBAC2_chr13_100020041_ENST00000403766_length(amino acids)=158AA_BP=83
MALRLLRRAARGAAAAALLRLKASLAADIPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKGGMINWN

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for CLYBL-UBAC2


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for CLYBL-UBAC2


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for CLYBL-UBAC2


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource